Henk Rozemuller

1.3k total citations
33 papers, 893 citations indexed

About

Henk Rozemuller is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Henk Rozemuller has authored 33 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 9 papers in Immunology. Recurrent topics in Henk Rozemuller's work include Mesenchymal stem cell research (10 papers), Virus-based gene therapy research (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Henk Rozemuller is often cited by papers focused on Mesenchymal stem cell research (10 papers), Virus-based gene therapy research (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Henk Rozemuller collaborates with scholars based in Netherlands, United States and Germany. Henk Rozemuller's co-authors include Anton C. Martens, Henk‐Jan Prins, Wouter J.A. Dhert, Joost D. de Bruijn, Benno A. Naaijkens, R. van Dijkhuizen‐Radersma, Frank W. Janssen, Viviènne Verweij, Anton Hagenbeek and Debby Gawlitta and has published in prestigious journals such as Blood, Clinical Cancer Research and Annals of the Rheumatic Diseases.

In The Last Decade

Henk Rozemuller

32 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henk Rozemuller Netherlands 15 333 285 211 195 163 33 893
Shuichi Ohta Japan 15 538 1.6× 512 1.8× 292 1.4× 163 0.8× 118 0.7× 46 1.3k
Véronique Decot France 18 398 1.2× 275 1.0× 340 1.6× 164 0.8× 69 0.4× 58 1.1k
Rachel A. Oldershaw United Kingdom 13 261 0.8× 505 1.8× 298 1.4× 116 0.6× 122 0.7× 30 1.2k
Kathryn Futrega Australia 19 304 0.9× 235 0.8× 213 1.0× 313 1.6× 74 0.5× 41 952
Gordon D. Wu United States 15 304 0.9× 248 0.9× 515 2.4× 99 0.5× 60 0.4× 56 1.2k
Alain Langonné France 17 736 2.2× 494 1.7× 352 1.7× 222 1.1× 51 0.3× 22 1.5k
Janet M. Kerr United States 14 451 1.4× 762 2.7× 218 1.0× 246 1.3× 83 0.5× 16 1.7k
Nancy S. Ricalton United States 9 341 1.0× 185 0.6× 206 1.0× 170 0.9× 37 0.2× 12 1.0k
Valeria Rasini Italy 12 501 1.5× 258 0.9× 203 1.0× 67 0.3× 159 1.0× 18 1000
Lynda O’Rear United States 15 409 1.2× 593 2.1× 293 1.4× 147 0.8× 45 0.3× 22 1.4k

Countries citing papers authored by Henk Rozemuller

Since Specialization
Citations

This map shows the geographic impact of Henk Rozemuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Rozemuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Rozemuller more than expected).

Fields of papers citing papers by Henk Rozemuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk Rozemuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Rozemuller. The network helps show where Henk Rozemuller may publish in the future.

Co-authorship network of co-authors of Henk Rozemuller

This figure shows the co-authorship network connecting the top 25 collaborators of Henk Rozemuller. A scholar is included among the top collaborators of Henk Rozemuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk Rozemuller. Henk Rozemuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swart, Joost F., Sytze de Roock, Frans M.A. Hofhuis, et al.. (2014). Mesenchymal stem cell therapy in proteoglycan induced arthritis. Annals of the Rheumatic Diseases. 74(4). 769–777. 30 indexed citations
2.
Guichelaar, Teun, Maarten E. Emmelot, Henk Rozemuller, et al.. (2013). Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells. Clinical Cancer Research. 19(6). 1467–1475. 22 indexed citations
3.
Boome, Liane te, Caroline A. Lindemans, Henk Rozemuller, et al.. (2013). Treatment of steroid-resistant grade II to IV acute Gvhd by infusion of mesenchymal stromal cells expanded with platelet lysate: a phase I/II study. 48. 1 indexed citations
4.
Delemarre, Eveline M., Sarah Roord, Theo van den Broek, et al.. (2013). Brief Report: Autologous Stem Cell Transplantation Restores Immune Tolerance in Experimental Arthritis by Renewal and Modulation of the Teff Cell Compartment. Arthritis & Rheumatology. 66(2). 350–356. 10 indexed citations
5.
Prins, Henk‐Jan, Hugo Fernandes, Henk Rozemuller, et al.. (2012). Spatial distribution and survival of human and goat mesenchymal stromal cells on hydroxyapatite andβ-tricalcium phosphate. Journal of Tissue Engineering and Regenerative Medicine. 10(3). 233–244. 11 indexed citations
6.
Noort, Willy A., Marish I.F.J. Oerlemans, Henk Rozemuller, et al.. (2011). Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Journal of Cellular and Molecular Medicine. 16(8). 1827–1839. 80 indexed citations
7.
Groen, Richard W.J., Martin F. M. de Rooij, Kinga A. Kocemba‐Pilarczyk, et al.. (2011). N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation. Haematologica. 96(11). 1653–1661. 32 indexed citations
8.
Rozemuller, Henk, et al.. (2010). Prospective Isolation of Mesenchymal Stem Cells from Multiple Mammalian Species Using Cross-Reacting Anti-Human Monoclonal Antibodies. Stem Cells and Development. 19(12). 1911–1921. 61 indexed citations
9.
Reijmers, Rogier M., Richard W.J. Groen, Henk Rozemuller, et al.. (2009). Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood. 115(3). 601–604. 40 indexed citations
10.
Prins, Henk‐Jan, Henk Rozemuller, Viviènne Verweij, et al.. (2009). Bone-Forming Capacity of Mesenchymal Stromal Cells When Cultured in the Presence of Human Platelet Lysate as Substitute for Fetal Bovine Serum. Tissue Engineering Part A. 15(12). 3741–3751. 80 indexed citations
11.
Dijkhuizen‐Radersma, R. van, et al.. (2009). Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. Journal of Tissue Engineering and Regenerative Medicine. 4(2). 131–140. 114 indexed citations
12.
Reijmers, Rogier M., Richard W.J. Groen, Henk Rozemuller, et al.. (2009). Targeting EXT-1 Reveals a Crucial Role of Heparan Sulfate in the Growth of Multiple Myeloma.. Blood. 114(22). 1830–1830. 3 indexed citations
13.
Rozemuller, Henk, Ellen van der Spek, Viviènne Verweij, et al.. (2008). A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect. Haematologica. 93(7). 1049–1057. 35 indexed citations
14.
Rozemuller, Henk, et al.. (2004). Enhanced engraftment of human cells in RAG2/γc double-knockout mice after treatment with CL2MDP liposomes. Experimental Hematology. 32(11). 1118–1125. 29 indexed citations
15.
Kruyt, Moyo C., Natalja E. Fedorovich, Joost D. de Bruijn, et al.. (2003). Genetic marking with the ΔLNGFR‐gene for tracing goat cells in bone tissue engineering. Journal of Orthopaedic Research®. 22(4). 697–702. 14 indexed citations
16.
Rozemuller, Henk, et al.. (1998). In vivo targeting of leukemic cells using diphtheria toxin fused to murine GM-CSF. Leukemia. 12(5). 710–717. 3 indexed citations
17.
Rozemuller, Henk, Wim Terpstra, Mark Lawler, et al.. (1998). GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF. Leukemia. 12(12). 1962–1970. 7 indexed citations
18.
Visser, Jan, et al.. (1996). The expression of cytokine receptors by purified hemopoietic stem cells. Stem Cells. 11(S2). 49–55. 13 indexed citations
19.
Rozemuller, Henk, et al.. (1995). Biotinylation of interleukin-2 (IL-2) for flow cytometric analysis of IL-2 receptor expression Comparison of different methods. Journal of Immunological Methods. 184(1). 101–112. 18 indexed citations
20.
Rozemuller, Henk, et al.. (1992). 3.6 A sensitive method to detect cell surface receptors using biotinylated growth factors. Progress in Histochemistry and Cytochemistry. 26(1-4). 119–123. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuichi Ohta Breakdown of academic impact, for papers by Véronique Decot Breakdown of academic impact, for papers by Rachel A. Oldershaw Breakdown of academic impact, for papers by Kathryn Futrega Breakdown of academic impact, for papers by Gordon D. Wu Breakdown of academic impact, for papers by Alain Langonné Breakdown of academic impact, for papers by Janet M. Kerr Breakdown of academic impact, for papers by Nancy S. Ricalton Breakdown of academic impact, for papers by Valeria Rasini Breakdown of academic impact, for papers by Lynda O’Rear
Rankless by CCL
2026